DRIZALMA SPRINKLE

Serial Number 97779623
732

Registration Progress

Application Filed
Feb 3, 2023
Under Examination
Nov 21, 2023
Approved for Publication
Sep 26, 2023
Published for Opposition
Sep 26, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Nov 21, 2025 113 days

Trademark Image

DRIZALMA SPRINKLE

Basic Information

Serial Number
97779623
Filing Date
February 3, 2023
Published for Opposition
September 26, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
732
Status Date
May 20, 2025
Application
Pending
Classes
005

Rights Holder

Sun Pharmaceutical Industries Limited

16
Address
Sun House, Plot No. 201 B/1
Western Express Highway, Goregaon - East
Mumbai, Maharashtra 400063
IN

Ownership History

Sun Pharmaceutical Industries Limited

Original Applicant
16
Mumbai, Maharashtra IN

Sun Pharmaceutical Industries Limited

Owner at Publication
16
Mumbai, Maharashtra IN

Legal Representation

Attorney
Craig Kuchii

USPTO Deadlines

Next Deadline
113 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
November 21, 2025
Extension Available
Until November 21, 2024

Application History

26 events
Date Code Type Description Documents
May 21, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 20, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 20, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 20, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 27, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 22, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 15, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 15, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
May 8, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 7, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 7, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
May 7, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 21, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 26, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 26, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 6, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 17, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 17, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 17, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 17, 2023 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 17, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 12, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 24, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 23, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 7, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neurologic disorders, disorders of the nervous system, mental illness, major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, chronic musculoskeletal pain

Additional Information

Design Mark
The mark consists of the stylized wording "DRIZALMA SPRINKLE" presented horizontally, with three dots forming in part the vertical side of the letter "D".
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "DRIZALMA" has no meaning in a foreign language.

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SPRINKLE"